MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Weight Gain | D015430 | 101 associated lipids |
Hypothermia | D007035 | 19 associated lipids |
Noladin ether is a lipid of Glycerolipids (GL) class. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity and Competitive inhibition. Noladin ether often locates in Synaptosomes and Tissue membrane. The associated genes with Noladin Ether are IMPACT gene. The related lipids are noladin ether and Fatty Alcohols.
To understand associated biological information of noladin ether, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with noladin ether
MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Weight Gain | D015430 | 101 associated lipids |
Hypothermia | D007035 | 19 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hayase T et al. | Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. | 2005 | Behav Pharmacol | pmid:16148444 |
Venderova K et al. | Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. | 2005 | Exp. Neurol. | pmid:15899265 |
Sancho R et al. | Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. | 2005 | J. Immunol. | pmid:16148147 |
Straiker A and Mackie K | Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. | 2005 | J. Physiol. (Lond.) | pmid:16179366 |
Shoemaker JL et al. | Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. | 2005 | J. Pharmacol. Exp. Ther. | pmid:16081674 |
Shoemaker JL et al. | The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15901805 |
Avraham Y et al. | Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. | 2005 | Brain Res. Bull. | pmid:15763177 |
Unzicker C et al. | Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? | 2005 | Neurochem. Res. | pmid:16341592 |
Guo J and Ikeda SR | Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. | 2004 | Mol. Pharmacol. | pmid:14978245 |
Duncan M et al. | Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor. | 2004 | Br. J. Pharmacol. | pmid:15148262 |
Oka S et al. | Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. | 2003 | J. Neurochem. | pmid:12787057 |
Appendino G et al. | Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors. | 2003 | Bioorg. Med. Chem. Lett. | pmid:12467613 |
Juntunen J et al. | Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether. | 2003 | J. Med. Chem. | pmid:14584958 |
van der Stelt M et al. | Acute neuronal injury, excitotoxicity, and the endocannabinoid system. | 2002 Oct-Dec | Mol. Neurobiol. | pmid:12428763 |
Laine K et al. | Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:12356827 |
Milton NG | Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. | 2002 | Neurosci. Lett. | pmid:12384227 |
Fezza F et al. | Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. | 2002 | FEBS Lett. | pmid:11904167 |
Hanus L et al. | 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11259648 |
pmid: |